Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancerJanet Mendonca(Sidney Kimmel Comprehensive Cancer Center), Sushant K. Kachhap(Johns Hopkins University)OncotargetJuly 7, 201410.18632/oncotarget.2174Cited by 63SaveCiteExport RISWatch citationsRelated PapersCombining the pan‐aurora kinase inhibitor <scp>AMG</scp> 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer|Cancer Medicine|2014|30